MedTrace Logo

Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI

NCT02587663 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2019-05-16

No results posted yet for this study

Summary

This clinical trial studies mammography and targeted ultrasound with or without whole-breast ultrasound or contrast-enhanced magnetic resonance imaging (MRI) in finding out the extent of disease before surgery in patients with newly diagnosed breast cancer. New diagnostic imaging procedures, such as whole-breast ultrasound or contrast-enhanced MRI, may help find out how far breast cancer has spread. It is not yet known whether mammography and targeted ultrasound are more effective with or without whole-breast ultrasound or contrast-enhanced MRI in finding out how far breast cancer has spread.

Conditions

  • Ductal Breast Carcinoma In Situ
  • Stage IA Breast Cancer
  • Stage IB Breast Cancer
  • Stage II Breast Cancer

Interventions

PROCEDURE

Contrast-enhanced Magnetic Resonance Imaging

Undergo bilateral breast contrast enhanced MRI

PROCEDURE

Mammography

Undergo bilateral mammography

PROCEDURE

Therapeutic Conventional Surgery

Undergo breast conserving surgery

PROCEDURE

Ultrasonography

Undergo bilateral whole-breast ultrasound

PROCEDURE

Ultrasonography

Undergo targeted breast ultrasound

OTHER

Gadolinium

Contrast agent used in MRI

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Southern California

    lead OTHER

Principal Investigators

  • Linda Hovanessian-Larsen · University of Southern California

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-20
Primary Completion
2011-11-20
Completion
2012-11-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02587663 on ClinicalTrials.gov